We have previously provided evidence that in the AChR+ MG thymus, there is a Th17 cell signature characterized by the presence of effector pathogenic Th17 cells that cross-talk with TECs to over-produce IL-17. This evidence concerns the gene IL17A and myasthenia gravis.